Search results
Showing 101 to 150 of 592 results for pregnancy
Recommendation ID NG207/01 Question Prevention of prolonged pregnancy: At what gestational age should induction of labour be offered in...
ID NG126/01 Question Early pregnancy assessment units: A national evaluation of early pregnancy assessment unit service...
injury by 2025. Safety – multiple pregnancy Increasing adherence to NICE guidance for multiple pregnancy helps to...
This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.
Hybrid closed loop systems for managing blood glucose levels in type 1 diabetes (TA943)
Evidence-based recommendations on hybrid closed loop systems for managing blood glucose levels in type 1 diabetes.
This quality standard covers assessing and managing renal and ureteric stones in children, young people and adults. It describes high-quality care in priority areas for improvement.
This guideline covers supporting the social and emotional wellbeing of vulnerable children under 5 through home visiting, childcare and early education. It aims to optimise care for young children who need extra support because they have or are at risk of social or emotional problems.
involves taking 2 different medicines to end the pregnancy, usually 1 or 2 days apart. The pregnancy is passed through the...
Healthy start vitamins: special report on cost effectiveness (ECD5)
Healthy start vitamins: special report on cost effectiveness
How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period?
Question How safe are drugs used to treat bipolar disorder in pregnancy and the postnatal period? Any explanatory notes(if applicable)
area. In our society, prospective parents invest a great deal in their pregnancies in a way that would have been unthinkable to our...
This quality standard covers managing faecal (bowel) incontinence in adults (aged 18 and over) in the community (at home and in care homes) and in all hospital departments. It includes assessment of bowel control problems, advice and support, and treatment options. It describes high-quality care in priority areas for improvement.
View quality statements for QS54Show all sections
Bronchiectasis (non-cystic fibrosis), acute exacerbation: antimicrobial prescribing (NG117)
This guideline sets out an antimicrobial prescribing strategy for managing and preventing acute exacerbations of bronchiectasis (non-cystic fibrosis). It aims to optimise antibiotic use and reduce antibiotic resistance.
View recommendations for NG117Show all sections
Women can develop mental ill health for the first time during pregnancy, and pre-existing mental health conditions can get worse in the...
What are the implications of FH for the safety of a mother during pregnancy and what are the risks of fetal malformations attributable...
The proportion of pregnancies resulting in a neonatal death or still birth
The proportion of pregnancies resulting in a neonatal death or still birth Subject(s): Pregnancy and neonates, Mortality
Recommendation ID NG207/02 Question Prevention of prolonged pregnancy: Based on individual patient data meta-analysis, what is the...
during pregnancy for women in higher-risk groups: How effective is pelvic floor muscle training in preventing pelvic floor dysfunction...
publication of NICE Guidelines for weight management before, during and after pregnancy (PH27). The service is aimed at obese pregnant...
This quality standard covers the care of pregnant women or pregnant people who are considering having or may need to have a caesarean birth, including those who have had a caesarean birth in the past. It includes decision making, reducing the risk of complications and care after a caesarean birth. It describes high-quality care in priority areas for improvement.
View quality statements for QS32Show all sections
Sections for QS32
- Quality statements
- Quality statement 1: Vaginal birth after a caesarean birth
- Quality statement 2: Request for a caesarean birth: maternity team involvement
- Quality statement 3: Request for a caesarean birth: anxiety
- Quality statement 4: Consultant obstetrician involvement in decision making for planned caesarean birth
- Quality statement 5: Timing of planned caesarean birth
- Quality statement 6: Consultant obstetrician involvement in decision making for unplanned caesarean birth
- Quality statement 7: The use of fetal blood sampling
disorder) in pregnancy? Any explanatory notes(if applicable) Anxiety disorders are often not identified or treated in...
In development [GID-NG10191] Expected publication date: 13 November 2024
guidance (updated) Antenatal care for uncomplicated pregnancies (updated) Hypertension in pregnancy: diagnosis and...
structured clinical management for moderate to severe personality disorders in pregnancy and the postnatal period effective at improving...
effectiveness of corticosteroids for women with severe nausea and vomiting in pregnancy? Any explanatory notes(if applicable) For a...
in helping women with diabetes to achieve blood glucose targets before pregnancy? Any explanatory notes(if applicable) Babies born to...
This guideline covers assessing and reducing the risk of venous thromboembolism (VTE or blood clots, including deep vein thrombosis and pulmonary embolism) in people aged 16 and over in hospital. It aims to help healthcare professionals identify people most at risk and describes interventions that can be used to reduce the risk of VTE.
In development [GID-NG10182] Expected publication date: TBC
Guidance on the use of riluzole (Rilutek) for the treatment of motor neurone disease (TA20)
Evidence-based recommendations on the use of riluzole (Rilutek) for treating motor neurone disease (MND).
This quality standard covers contraception for women, including emergency contraception. It describes high-quality care in priority areas for improvement.
View quality statements for QS129Show all sections
This guideline covers assessing, diagnosing and managing physical health problems of people in prison. It aims to improve health and wellbeing in the prison population by promoting more coordinated care and more effective approaches to prescribing, dispensing and supervising medicines.
not be used by any woman or girl able to have children unless there is a pregnancy prevention programme (PPP) in place. Valproate is...
This guideline covers diagnosing and treating jaundice, which is caused by increased levels of bilirubin in the blood, in newborn babies (neonates). It aims to help detect or prevent very high levels of bilirubin, which can be harmful if not treated.
Exagamglogene autotemcel for treating sickle cell disease [ID4016]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 11 April 2024.
Vamorolone for treating Duchenne muscular dystrophy [ID4024]: draft guidance
We are listening to your views on this Technology appraisal guidance. Comments close 24 April 2024.
We are listening to your views on this Technology appraisal guidance. Comments close 22 April 2024.
care for them, about the use of nicotine-containing e‑cigarettes during pregnancy? Any explanatory notes(if applicable) For a short...
NICE has developed a medtech innovation briefing (MIB) on Natural Cycles for monitoring fertility .
is no good evidence that aspirin causes harm to the baby in early pregnancy when taken at lower doses, or at higher doses taken short...
Chronic heart failure in adults: diagnosis and management (NG106)
This guideline covers diagnosing and managing chronic heart failure in people aged 18 and over. It aims to improve diagnosis and treatment to increase the length and quality of life for people with heart failure.
Our guidelines make evidence based, best practice recommendations. These help to improve patient safety and reduce the risk of harm across the health system.
Pre-eclampsia is a multi-system hypertensive disorder of pregnancy that affects approximately 3% of all pregnancies. NICE...
Lumella point-of-care test for assessing pre-eclampsia risk (MIB287)
NICE has developed a medtech innovation briefing (MIB) on Lumella point-of-care test for assessing pre-eclampsia risk .
Our health inequalities guidance supports strategies that improve population health as a whole, while offering particular benefit to the most disadvantaged
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
Developmental follow-up of children and young people born preterm (NG72)
This guideline covers the developmental follow-up of babies, children and young people under 18 years who were born preterm (before 37+0 weeks of pregnancy). It explains the risk of different developmental problems and disorders, and specifies what extra assessments and support children born preterm might need during their growth and development.
This quality standard covers identifying and managing familial hypercholesterolaemia (FH) in children, young people and adults. FH is a type of high cholesterol that runs in families and increases the risk of heart disease. The quality standard describes high-quality care in priority areas for improvement.
View quality statements for QS41Show all sections
Sections for QS41
- Quality statements
- Quality statement 1: Diagnosis
- Quality statement 2: Specialist referral
- Quality statement 3: DNA testing
- Quality statement 4: Diagnosis in children under 10 years
- Quality statement 5: Cascade testing
- Quality statement 6: Drug treatment in adults
- Quality statement 7: Drug treatment in children
which increase awareness of the risks associated with excess weight in pregnancy and other stages of childbearing. Our programmes...
NG62/4 Question Association between treating infections in pregnancy and rates of cerebral palsy:- What is the association between...